Skip to main content
Caplight Logo









Portrai

Portrai

Private
SeoulHealthcare & Life Scienceshttps://portrai.io/en

Last Round

Series B

Dec 2, 2025

Est. Valuation

$14.55M

Total Funding Raised

$14.99M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Portrai is a biotechnology and artificial intelligence company that has developed an AI-powered spatial biology platform for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

spatial transcriptomicstumor microenvironmentprecision oncologydrug discoverytechbiobiomarker developmentspatial biologymultimodal AIAI pathologymechanism of actionMOAin silicoAI drug discoveryfoundation modelfrontier AI labAI agent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Portrai Comparables

Compare Portrai with similar companies based on industry and business-model similarity.

Portrai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Digital Biology
82%
Nucleai
81%
Noetik
78%

Portrai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 2, 2025
Series AMar 1, 2023
SeedOct 6, 2021
SeedAug 1, 2021

Key People

Founding team and executive leadership

Kwon Joong Na

Chief Medical Officer, Co-Founder

Founding Team

Daeseung Lee

CEO

Executive Team

Hongyoon Choi

Chief Technology Officer

Executive Team

Portrai Investors

Notable investors and investment history

Portrai investors
InvestorRounds
BNH INVESTMENTSeries B
CKD Venture CapitalSeries B
DSC InvestmentSeries A, Seed
Kakao VenturesSeries A, Series B, Seed
Saehan VenturesSeed
BonAngels Venture PartnersSeries B
Pearl Abyss CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 5, representing 24% of headcount.

  • Jul 24, 2026

    Monthly visitors increased 130% MoM, reaching 1.6K.

Portrai Filings

Explore SEC and related filing metadata, where available.

Portrai filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Portrai's valuation, stock price, and market status.

Is Portrai a public or private company?

Portrai is a private company.

What is the current stock price of Portrai?

Portrai is a private company with no public stock price. No recent secondary market data is available.

How much is Portrai worth (valuation)?

Valuation information for Portrai is not publicly available.

Can I buy Portrai stock?

Portrai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Portrai's last funding round?

Portrai's most recent funding round was Series B on December 2, 2025.

Who are the main investors in Portrai?

Key investors in Portrai include STIC Ventures.

Will Portrai IPO soon?

No public IPO plans have been announced for Portrai.

How can I track Portrai secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Portrai's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range20
Year Founded2021
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?